Neuro-Oncology
Reviews


Volume 22 Number 6
June 2020


Home > Publications > Neuro-Oncology Reviews > Volume 22, Year 2020 > Number 6, June



Contents


CENTRAL NERVOUS SYSTEM TUMORS




GLIOMAS


HIGH-GRADE GLIOMAS


LOW-GRADE GLIOMAS




DIFFUSE ASTROCYTIC AND OLIGODENDROGLIAL TUMORS


GLIOBLASTOMA


DIFFUSE MIDLINE GLIOMA




EMBRYONAL TUMORS


MEDULLOBLASTOMA


CNS EMBRYONAL TUMOR


HIGH-GRADE NEUROEPITHELIAL TUMOR WITH BCOR ALTERATION




MESENCHIMAL NON-MENINGOTHELIAL TUMORS


HEMANGIOBLASTOMA




LYMPHOMAS




FAMILIAL TUMOR SYNDROMES





Central nervous system tumors

Review

Bielecka J, Markiewicz-Żukowska R.
The Influence of Nutritional and Lifestyle Factors on Glioma Incidence.
Nutrients. 2020 Jun 17. 2020;12(6):E1812. Doi 10.3390/nu12061812. _



Review

Bull KS, Hornsey S, Kennedy CR, Darlington AE, Grootenhuis MA, Hargrave D, Liossi C, Shepherd JP, Walker DA, Morris C.
Systematic review: measurement properties of patient-reported outcome measures evaluated with childhood brain tumor survivors or other acquired brain injury.
Neurooncol Pract. 2019 Dec 8. 2020;7(3):277-287. Doi 10.1093/nop/npz064. _



Review

DeNunzio NJ, Yock TI.
Modern Radiotherapy for Pediatric Brain Tumors.
Cancers (Basel). 2020 Jun 11;12(6):E1533. Doi 10.3390/cancers12061533. _



Review

Hanz SZ, Adeuyan O, Lieberman G, Hennika T.
Clinical trials using molecular stratification of pediatric brain tumors.
Transl Pediatr. 2020 Apr;9(2):144-156. Doi 10.21037/tp.2020.03.04. _



Review
Meta-analysis

Lee KH, Seong HJ, Kim G, Jeong GH, Kim JY, Park H, Jung E, Kronbichler A, Eisenhut M, Stubbs B, Solmi M, Koyanagi A, Hong SH, Dragioti E, de Rezende LFM, Jacob L, Keum N, van der Vliet HJ, Cho E, Veronese N, Grosso G, Ogino S, Song M, Radua J, Jung SJ, Thompson T, Jackson SE, Smith L, Yang L, Oh H, Choi EK, Shin JI, Giovannucci EL, Gamerith G.
Consumption of Fish and ω-3 Fatty Acids and Cancer Risk: An Umbrella Review of Meta-Analyses of Observational Studies.
Adv Nutr. 2020 Jun 3. 2020:nmaa055. doi: 10.1093/advances/nmaa055. _



Review

Lohmann P, Galldiks N, Kocher M, Heinzel A, Filss CP, Stegmayr C, Mottaghy FM, Fink GR, Jon Shah N, Langen KJ.
Radiomics in neuro-oncology: Basics, workflow, and applications.
Methods. 2020 Jun 6. 2020;S1046-2023(19)30317-2. Doi 10.1016/j.ymeth.2020.06.003. _



Statistical study

Ostrom QT, Truitt G, Gittleman H, Brat DJ, Kruchko C, Wilson R, Barnholtz-Sloan JS.
Relative survival after diagnosis with a primary brain or other central nervous system tumor in the National Program of Cancer Registries, 2004 to 2014.
Neurooncol Pract. 2019 Dec 16. 2020;7(3):306-312. Doi 10.1093/nop/npz059. _



Review

Raviraj R, Nagaraja SS, Selvakumar I, Mohan S, Nagarajan D.
The epigenetics of brain tumors and its modulation during radiation: A review.
Life Sci. 2020 Jun 15. 2020;256:117974. Doi 10.1016/j.lfs.2020.117974. _



Gliomas

Meta-analysis

Cai Z, Yang S, Li X, Chen F, Li W.
Viral infection and glioma: a meta-analysis of prognosis.
BMC Cancer. 2020 Jun 12. 2020;20(1):549. Doi 10.1186/s12885-020-06796-3. _



Review

Grabowski MM, Sankey EW, Ryan KJ, Chongsathidkiet P, Lorrey SJ, Wilkinson DS, Fecci PE.
Immune suppression in gliomas.
J Neurooncol. 2020 Jun 15. 2020;10.1007/s11060-020-03483-y. Doi 10.1007/s11060-020-03483-y. _



Review

Hill CS, Devesa SC, Ince W, Borg A, Aquilina K.
A systematic review of ongoing clinical trials in optic pathway gliomas.
Childs Nerv Syst. 2020 Jun 18. 2020;10.1007/s00381-020-04724-1. Doi 10.1007/s00381-020-04724-1. _



Review

Huang M, Patel J, Patel BC.
Optic Nerve Glioma.
StatPearls [Internet]. 2020 May 4. Books/NBK557878. _



Review

Kirby AJ, Finnerty GT.
New strategies for managing adult gliomas.
J Neurol. 2020 Jun 15. 2020;10.1007/s00415-020-09884-3. Doi 10.1007/s00415-020-09884-3. _



Review

Quartuccio N, Laudicella R, Vento A, Pignata S, Mattoli MV, Filice R, Comis AD, Arnone A, Baldari S, Cabria M, Cistaro A.
The Additional Value of 18F-FDG PET and MRI in Patients with Glioma: A Review of the Literature from 2015 to 2020.
Diagnostics (Basel). 2020 May 29. 2020;10(6):357. Doi 10.3390/diagnostics10060357. _



Review

Roth P, Hottinger AF, Hundsberger T, Läubli H, Schucht P, Reinert M, Mamot C, Roelcke U, Pesce G, Hofer S, Weller M.
A contemporary perspective on the diagnosis and treatment of diffuse gliomas in adults.
Swiss Med Wkly. 2020 Jun 5. 2020;150:w20256. Doi 10.4414/smw.2020.20256. _



Review

Soldozy S, Skaff A, Soldozy K, Sokolowski JD, Norat P, Yagmurlu K, Sharifi KA, Tvrdik P, Park MS, Kalani MYS, Jane JA, Syed HR.
From Bench to Bedside, the Current State of Oncolytic Virotherapy in Pediatric Glioma.
Neurosurgery. 2020 Jun 15. 2020;nyaa247. Doi 10.1093/neuros/nyaa247. _



Review

Trifiletti DM, Malouff TD, McGovern SL, Weathers SP, Wang TJC, Lassman AB, Cahill DP, Shih HA, Brown PD.
Repeat Radiation in the Brain: Managing Patients With Locally Recurrent Glioma.
Semin Radiat Oncol. 2020 Jun 2. 2020;30(3):218-222. Doi 10.1016/j.semradonc.2020.02.005. _



Review
Meta-Analysis

Yu Y, Ma Y, Sun M, Jiang W, Yuan T, Tong D.
Meta-analysis of the diagnostic performance of diffusion magnetic resonance imaging with apparent diffusion coefficient measurements for differentiating glioma recurrence from pseudoprogression.
Medicine (Baltimore). 2020 Jun 5. 2020;99(23):e20270. Doi 10.1097/MD.0000000000020270. _



High-grade gliomas


Recommendations

Boxerman JL, Quarles CC, Hu LS, Erickson BJ, Gerstner ER, Smits M, Kaufmann TJ, Barboriak DP, Huang RH, Wick W, Weller M, Galanis E, Kalpathy-Cramer J, Shankar L, Jacobs P, Chung C, van den Bent MJ, Chang S, Al Yung WK, Cloughesy TF, Wen PY, Gilbert MR, Rosen BR, Ellingson BM, Schmainda KM; Jumpstarting Brain Tumor Drug Development Coalition Imaging Standardization Steering Committee.
Consensus Recommendations for a Dynamic Susceptibility Contrast MRI Protocol for Use in High-Grade Gliomas.
Neuro Oncol. 2020 Jun 9. 2020;noaa141. Doi 10.1093/neuonc/noaa141. _



Review
Meta-analysis

Cho SJ, Kim HS, Suh CH, Park JE.
Radiological Recurrence Patterns after Bevacizumab Treatment of Recurrent High-Grade Glioma: A Systematic Review and Meta-Analysis.
Korean J Radiol. 2020 May 29. 2020;21(7):908-918. Doi 10.3348/kjr.2019.0898. _



Guidelines

Erker C, Tamrazi B, Poussaint TY, Mueller S, Mata-Mbemba D, Franceschi E, Brandes AA, Rao A, Haworth KB, Wen PY, Goldman S, Vezina G, MacDonald TJ, Dunkel IJ, Morgan PS, Jaspan T, Prados MD, Warren KE.
Response assessment in paediatric high-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Lancet Oncol. 2020 Jun 1. 2020;21(6):e317-e329. Doi 10.1016/S1470-2045(20)30173-X. _



Retrospective study

Nunna RS, Khalid S, Behbahani M, Mehta AI.
Pediatric primary high-grade spinal glioma: a National Cancer Database analysis of current patterns in treatment and outcomes.
Childs Nerv Syst. 2020 Jun 12. 2020;10.1007/s00381-020-04722-3. Doi 10.1007/s00381-020-04722-3. _



Review

Ruggiero A, Ariano A, Triarico S, Capozza MA, Romano A, Maurizi P, Mastrangelo S, Attinà G.
Temozolomide and oral etoposide in children with recurrent malignant brain tumors.
Drugs Context. 2020 Jun 2. 2020;9:2020-3-1. Doi 10.7573/dic.2020-3-1. _



Review

Shah PP, White T, Khalafallah AM, Romo CG, Price C, Mukherjee D.
A systematic review of tumor treating fields therapy for high-grade gliomas.
J Neurooncol. 2020 Jun 23. 2020;10.1007/s11060-020-03563-z. Doi 10.1007/s11060-020-03563-z. _



Low-grade gliomas


Guidelines

Fangusaro J, Witt O, Hernáiz Driever P, Bag AK, de Blank P, Kadom N, Kilburn L, Lober RM, Robison NJ, Fisher MJ, Packer RJ, Young Poussaint T, Papusha L, Avula S, Brandes AA, Bouffet E, Bowers D, Artemov A, Chintagumpala M, Zurakowski D, van den Bent M, Bison B, Yeom KW, Taal W, Warren KE.
Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Lancet Oncol. 2020 Jun 1. 2020;21(6):e305-e316. Doi 10.1016/S1470-2045(20)30064-4. _



Diffuse astrocytic and oligodendroglial tumors



Glioblastoma


Review

Alexandru O, Horescu C, Sevastre AS, Cioc CE, Baloi C, Oprita A, Dricu A.
Receptor tyrosine kinase targeting in glioblastoma: performance, limitations and future approaches.
Contemp Oncol (Pozn). 2020 Mar 30. 2020;24(1):55-66. Doi 10.5114/wo.2020.94726. _



Retrospective study
Review

Armocida D, Pesce A, Di Giammarco F, Frati A, Salvati M, Santoro A.
Histological, molecular, clinical and outcomes characteristics of Multiple Lesion Glioblastoma. A retrospective monocentric study and review of literature.
Neurocirugia (Astur). 2020 Jun 18. 2020:S1130-1473(20)30064-6. Doi: 10.1016/j.neucir.2020.04.003.. _



Review

Bajetto A, Thellung S, Dellacasagrande I, Pagano A, Barbieri F, Florio T.
Cross talk between mesenchymal and glioblastoma stem cells: Communication beyond controversies.
Stem Cells Transl Med. 2020 Jun 15. 2020;10.1002/sctm.20-0161. Doi 10.1002/sctm.20-0161. _



Review

Botros D, Dux H, Price C, Khalafallah AM, Mukherjee D.
Assessing the efficacy of repeat resections in recurrent glioblastoma: a systematic review.
Neurosurg Rev. 2020 Jun 13. 2020;10.1007/s10143-020-01331-1. Doi 10.1007/s10143-020-01331-1. _



Meetings
Requirements

Grossman SA, Romo CG, Rudek MA, Supko J, Fisher J, Nabors LB, Wen PY, Peereboom DM, Ellingson BM, Elmquist W, Barker FG, Kamson D, Sarkaria JN, Timmer W, Bindra RS, Ye X; Adult Brain Tumor Consortium.
Baseline Requirements for Novel Agents Being Considered for Phase II/III Brain Cancer Efficacy Trials: Conclusions from the Adult Brain Tumor Consortium's First Workshop on CNS Drug Delivery.
Neuro Oncol. 2020 Jun 7. 2020;noaa142. Doi 10.1093/neuonc/noaa142. _



Review

Herbener VJ, Burster T, Goreth A, Pruss M, von Bandemer H, Baisch T, Fitzel R, Siegelin MD, Karpel-Massler G, Debatin KM, Westhoff MA, Strobel H.
Considering the Experimental use of Temozolomide in Glioblastoma Research.
Biomedicines. 2020 Jun 4. 2020;8(6):151. Doi 10.3390/biomedicines8060151. _



Review
Meta-analysis

Jackson C, Choi J, Khalafallah AM, Price C, Bettegowda C, Lim M, Gallia G, Weingart J, Brem H, Mukherjee D.
A systematic review and meta-analysis of supratotal versus gross total resection for glioblastoma.
J Neurooncol. 2020 Jun 19. 2020;10.1007/s11060-020-03556-y. Doi 10.1007/s11060-020-03556-y. _



Case report
Review

Juškys R, Chomanskis .
Glioblastoma Following Traumatic Brain Injury: Case Report and Literature Review.
Cureus. 2020 May 7. 2020;12(5):e8019. Doi 10.7759/cureus.8019. _



Review

Lynes JP, Nwankwo AK, Sur HP, Sanchez VE, Sarpong KA, Ariyo OI, Dominah GA, Nduom EK.
Biomarkers for immunotherapy for treatment of glioblastoma.
J Immunother Cancer. 2020 May 30. 2020;8(1):e000348. Doi 10.1136/jitc-2019-000348. _



Case report
Review

Liu J, Shen L, Tang G, Tang S, Kuang W, Li H, Tian Y, Zhou Q.
Multiple extracranial metastases from glioblastoma multiforme: a case report and literature review.
J Int Med Res. 2020 Jun 18. 2020;48(6):300060520930459. Doi 10.1177/0300060520930459. _



Review

Majc B, Sever T, Zarić M, Breznik B, Turk B, Lah TT.
Epithelial-to-mesenchymal transition as the driver of changing carcinoma and glioblastoma microenvironment.
Biochim Biophys Acta Mol Cell Res. 2020 Jun 15. 2020;1867(10):118782. Doi 10.1016/j.bbamcr.2020.118782. _



Review

Mathen P, Rowe L, Mackey M, Smart D, Tofilon P, Camphausen K.
Radiosensitizers in the temozolomide era for newly diagnosed glioblastoma.
Neurooncol Pract. 2019 Nov 30. 2020;7(3):268-276. Doi 10.1093/nop/npz057. _



Review

Tan AC, Ashley DM, López GY, Malinzak M, Friedman HS, Khasraw M.
Management of glioblastoma: State of the art and future directions.
CA Cancer J Clin. 2020 Jun 1. 2020;10.3322/caac.21613. Doi 10.3322/caac.21613. _



Review
Meta-analysis

Trone JC, Vallard A, Sotton S, Ben Mrad M, Jmour O, Magné N, Pommier B, Laporte S, Ollier E.
Survival after hypofractionation in glioblastoma: a systematic review and meta-analysis.
Radiat Oncol. 2020 Jun 8. 2020;15(1):145. Doi 10.1186/s13014-020-01584-6. _



Review

Yekula A, Muralidharan K, Rosh ZS, Youngkin AE, Kang KM, Balaj L, Carter BS.
Liquid Biopsy Strategies to Distinguish Progression from Pseudoprogression and Radiation Necrosis in Glioblastomas.
Adv Biosyst. 2020 Jun 2. 2020;e2000029. Doi: 10.1002/adbi.202000029. _



Diffuse midline glioma


Book

Cohen KJ et al, PDQ Pediatric Treatment Editorial Board.
Childhood Brain Stem Glioma Treatment (PDQ®): Health Professional Version.
PDQ Cancer Inf Summ. 2020 Jun 8. Natl Cancer Inst. NBK65812. _



Guidelines

Cooney TM, Cohen KJ, Guimaraes CV, Dhall G, Leach J, Massimino M, Erbetta A, Chiapparini L, Malbari F, Kramer K, Pollack IF, Baxter P, Laughlin S, Patay Z, Young Poussaint T, Warren KE.
Response assessment in diffuse intrinsic pontine glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group.
Lancet Oncol. 2020 Jun 1. 2020;21(6):e330-e336. Doi 10.1016/S1470-2045(20)30166-2. _



Review

Felker J, Broniscer A.
Improving long-term survival in diffuse intrinsic pontine glioma.
Expert Rev Neurother. 2020 Jun 16. 2020;1-11. Doi 10.1080/14737175.2020.1775584. _



Embryonal tumors



Medulloblastoma


Book

Cohen KJ et al., PDQ Pediatric Treatment Editorial Board.
Childhood Medulloblastoma and Other Central Nervous System Embryonal Tumors Treatment (PDQ®): Health Professional Version.
PDQ Cancer Inf Summ. 2020 May 28. Natl Cancer Inst. NBK65981. _



Review

Laneve P, Caffarelli E.
The Non-coding Side of Medulloblastoma.
Front Cell Dev Biol. 2020 May 27. 2020;8:275. Doi 10.3389/fcell.2020.00275. _



Bibliometric analysis

Lu VM, Pendleton C, Brown DA, Lakomkin N, Cho S, Miller KJ, Daniels DJ.
Shaping Our Understanding of Medulloblastoma: A Bibliometric Analysis of the 100 Most Cited Articles.
Clin Neurol Neurosurg. 2020 May 23. 2020;194:105895. Doi 10.1016/j.clineuro.2020.105895. _



Case report
Review

Oishi M, Fujisawa H, Tsuchiya K, Nakajima Y.
Radiation-induced spinal cord cavernous malformations associated with medulloblastoma: a case report and literature review.
World Neurosurg. 2020 Jun 24. 2020:S1878-8750(20)31383-8. Doi 10.1016/j.wneu.2020.06.125. _



Review

Thompson EM, Ashley D, Landi D.
Current medulloblastoma subgroup specific clinical trials.
Transl Pediatr. 2020 Apr;9(2):157-162. Doi: 10.21037/tp.2020.03.03. _



CNS embryonal tumor




High-grade neuroepithelial tumor with bcor alteration


Review

De Lima L, Sürme MB, Gessi M, Mastronuzzi A, Miele E, Tamburrini G, Massimi L.
Central nervous system high-grade neuroepithelial tumor with BCOR alteration (CNS HGNET-BCOR)-case-based reviews.
Childs Nerv Syst. 2020 Jun 15. 2020;36(8):1589-1599. Doi 10.1007/s00381-020-04692-6. _



Mesenchimal non-meningothelial tumors



Hemangioblastoma


Case report
Review

Nayak N, Kumar A.
Cerebellar hemangioblastoma during pregnancy: Management options and review of literature.
Surg Neurol Int. 2020 May 23. 2020;11:123. Doi 10.25259/SNI_203_2020. _



Lymphomas

Perspective

Tsang M, Cleveland J, Rubenstein JL.
On point in primary CNS lymphoma.
Hematol Oncol. 2020 Jun 8. 2020;10.1002/hon.2761. Doi 10.1002/hon.2761. _



Familial tumor syndromes

Review

Roth J, Constantini S, Cinalli G.
Neurofibromatosis type 1-related hydrocephalus: causes and treatment considerations.
Childs Nerv Syst. 2020 Jun 6. 2020;10.1007/s00381-020-04719-y. Doi 10.1007/s00381-020-04719-y. _



bottom